Preprint A case of post-COVID-19 [ME/CFS] characterized by post-exertional malaise and low serum acylcarnitine level , 2022, Jinushi et al

preprint
A case of post-COVID-19 myalgic encephalomyelitis/chronic fatigue syndrome characterized by post-exertional malaise and low serum acylcarnitine level
2022 Jinushi et al

Abstract
COVID-19 afflicts patients with acute symptoms and longer-term sequelae. One of the sequelae is myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), which is often difficult to diagnose, having no established tests. In this article, we synthesize information from literature reviews on patients with ME/CSF that developed after recovery from COVID-19.

https://www.authorea.com/doi/full/10.22541/au.166970885.57585536/v1

 

No.

 

I'm afraid much of the research in this area from Japan and China is not worth the paper it's written on. It's strange because in some areas — such as solid-state physics — they excel.

"16. Kuratsune H, Yamaguti K, Watanabe Y, et al. Acylcarnitine and Chronic Fatigue Syndrome. in: Carnitine Today. De Simone C, Famularo G Eds. RG Landes Company, Austin, 1997:195-213"

I must get my hands on the latest issue of Carnitine Today...

 

don't shoot the messenger; I just copied and pasted the abstract

 

Yes, I realised that! This is more common than it should be. I've seen it dozens of times.